UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Application of Living Free Radical Polymerization for Nucleic Acid Delivery

Accounts of chemical research, 2012-07, Vol.45 (7), p.1089-1099

2012

Volltextzugriff (PDF)

HPMA-oligolysine copolymers for gene delivery: Optimization of peptide length and polymer molecular weight

Journal of controlled release, 2011-10, Vol.155 (2), p.303-311

2011

Volltextzugriff (PDF)

Synthesis and Evaluation of Cyclic Cationic Polymers for Nucleic Acid Delivery

ACS macro letters, 2013-12, Vol.2 (12), p.1047-1050

2013

Volltextzugriff (PDF)

Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release

Journal of controlled release, 2012-02, Vol.157 (3), p.445-454

2012

Volltextzugriff (PDF)

AP-2α: A Regulator of EGF Receptor Signaling and Proliferation in Skin Epidermis

The Journal of cell biology, 2006-01, Vol.172 (3), p.409-421

2006

Volltextzugriff (PDF)

Neuron-Targeted Copolymers with Sheddable Shielding Blocks Synthesized Using a Reducible, RAFT-ATRP Double-Head Agent

Journal of the American Chemical Society, 2012-10, Vol.134 (40), p.16554-16557

2012

Volltextzugriff (PDF)

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial

Journal of the American Academy of Dermatology, 2024-05, Vol.90 (5), p.986-993

2024

Volltextzugriff (PDF)

Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins

Journal of controlled release, 2009-02, Vol.133 (3), p.178-184

2009

Volltextzugriff (PDF)

The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA- co -oligolysine copolymer-coated adenovirus

Biomaterials, 2011-12, Vol.32 (35), p.9536-9545

2011

Volltextzugriff (PDF)

Dual Responsive, Stabilized Nanoparticles for Efficient In Vivo Plasmid Delivery

Angewandte Chemie (International ed.), 2013-05, Vol.52 (20), p.5377-5381

2013

Volltextzugriff (PDF)

Optimization of Tet1 ligand density in HPMA- co -oligolysine copolymers for targeted neuronal gene delivery

Biomaterials, 2013-12, Vol.34 (37), p.9632-9637

2013

Volltextzugriff (PDF)

Melittin-grafted HPMA-oligolysine based copolymers for gene delivery

Biomaterials, 2013-03, Vol.34 (9), p.2318-2326

2013

Volltextzugriff (PDF)

Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity

Journal of controlled release, 2015-05, Vol.205, p.155-161

2015

Volltextzugriff (PDF)

53863 Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 clinical trials of adults and children with atopic dermatitis

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB281-AB281

2024

Volltextzugriff (PDF)

641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

53894 Roflumilast foam 0.3% once daily in patients with seborrheic dermatitis: Improvement in patient reported outcomes and pruritus from a phase 3 trial (STRATUM)

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB304-AB304

2024

Volltextzugriff (PDF)

53817 Patient-reported outcomes with roflumilast foam 0.3% in patients with scalp and body psoriasis in the phase 3 ARRECTOR trial

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB276-AB276

2024

Volltextzugriff (PDF)

505 - Once-daily roflumilast cream 0.15% for atopic dermatitis: pooled results from INTEGUMENT-1/2 phase 3 trials

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii10-ii11

2024

Volltextzugriff (PDF)

Differential Requirements for ZAP-70 in TCR Signaling and T Cell Development

The Journal of immunology (1950), 1998-11, Vol.161 (9), p.4688-4694

1998

Volltextzugriff (PDF)

388 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: assessment of pruritus

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Volltextzugriff (PDF)

The Physician-Scientist

Journal of investigative dermatology, 2006-03, Vol.126 (3), p.527-527

2006

Volltextzugriff (PDF)

638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

Detecting Early Functional Damage in Glaucoma Suspect and Ocular Hypertensive Patients With the Multifocal VEP Technique

Journal of glaucoma, 2006-08, Vol.15 (4), p.321-327

2006

Volltextzugriff (PDF)

640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

504 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii9-ii10

2024

Volltextzugriff (PDF)

1 – 25 von 1.382

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.243)
Mit Volltextzugriff
(1.174)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(984)
Life Sciences & Biomedicine
(755)
Humans
(611)
Female
(353)
Male
(330)
Middle Aged
(224)
Biological And Medical Sciences
(223)
Adult
(202)
Medical Sciences
(186)
Aged
(183)
Animals
(181)
Physical Sciences
(138)
Technology
(98)
Oncology
(93)
Mice
(85)
Physics
(80)
Science & Technology - Other Topics
(78)
Adolescent
(77)
Biochemistry & Molecular Biology
(76)
Risk Factors
(71)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Nature
(21)
The New England Journal Of Medicine
(19)
Plos One
(18)
The American Surgeon
(16)
Cancer Research
(15)
Clinical Cancer Research
(15)
Blood
(14)
Nature Communications
(13)
The Journal Of High Energy Physics
(13)
Proceedings Of The National Academy Of Sciences - Pnas
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(20)
... seit 30 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Application of Living Free Radical Polymerization for Nucleic Acid Delivery

HPMA-oligolysine copolymers for gene delivery: Optimization of peptide length and polymer molecular weight

Synthesis and Evaluation of Cyclic Cationic Polymers for Nucleic Acid Delivery

Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release

AP-2α: A Regulator of EGF Receptor Signaling and Proliferation in Skin Epidermis

Neuron-Targeted Copolymers with Sheddable Shielding Blocks Synthesized Using a Reducible, RAFT-ATRP Double-Head Agent

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial

Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins

The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA- co -oligolysine copolymer-coated adenovirus

Dual Responsive, Stabilized Nanoparticles for Efficient In Vivo Plasmid Delivery

Optimization of Tet1 ligand density in HPMA- co -oligolysine copolymers for targeted neuronal gene delivery

Melittin-grafted HPMA-oligolysine based copolymers for gene delivery

Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity

53863 Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 clinical trials of adults and children with atopic dermatitis

641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis

53894 Roflumilast foam 0.3% once daily in patients with seborrheic dermatitis: Improvement in patient reported outcomes and pruritus from a phase 3 trial (STRATUM)

53817 Patient-reported outcomes with roflumilast foam 0.3% in patients with scalp and body psoriasis in the phase 3 ARRECTOR trial

505 - Once-daily roflumilast cream 0.15% for atopic dermatitis: pooled results from INTEGUMENT-1/2 phase 3 trials

Differential Requirements for ZAP-70 in TCR Signaling and T Cell Development

388 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: assessment of pruritus

The Physician-Scientist

638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial

Detecting Early Functional Damage in Glaucoma Suspect and Ocular Hypertensive Patients With the Multifocal VEP Technique

640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis

504 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis

Aktive Filter

Suchergebnisse filtern